MRNA vs RPRX: Fair Value Comparison
MRNA's model fair value sits 95.1% below its current price; RPRX's model fair value sits 34.5% below its current price. Of the two, RPRX trades further below its model estimate. Model estimates under stated assumptions. Data as of 2026-11-09.
| MRNA | RPRX | |
|---|---|---|
| Price | $269.00 | $68.77 |
| Model fair value (multi-method blend) | $13.09 | $45.04 |
| Model fair value differential | -95.1% | -34.5% |
| Methods with a model value above price | 2 of 2 | 6 of 8 |
| Fundamental strength | C- | B |
| Next earnings report | — | — |
More comparisons
VRTX vs MRNA · MRNA vs REGN · VRTX vs RPRX · REGN vs RPRX · All Biotechnology stocks · Compare any two stocks